Networking2Save: CDCs National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations — Centers for Disease Control - NCCDPHP funding opportunity
Centers for Disease Control - NCCDPHP · Federal agency

Networking2Save: CDCs National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations

Cigarette smoking and exposure to secondhand smoke (SHS) is the leading preventable cause of death in the United States, resulting in approximately 480,000 premature deaths and 16 million smoking-related illnesses. Cigar...

66
match
Award $350k–$500k Deadline 2984 days ago Location Alabama Type grant Level Federal Closed posted Apr 16, 2018
✦ AI Summary
  • Who can apply: Federal-level applicants (see eligibility for details).
  • Funding amount: $350,000 – $500,000, total pool ~$17,500,000.
  • Next deadline: June 18, 2018.
  • Issued by: Centers for Disease Control - NCCDPHP.
How was this generated?

The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.

AI-generated. Always verify with the official source.

Who can apply — at a glance

  • Eligible applicants: see the Eligibility tab for the criteria from the official announcement.
  • Where: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, District of Columbia.
  • Award: $350k–$500k. Total program pool: $17,500,000.
  • Matching funds: not required.
  • Deadline type: Fixed.

Compiled from the official listing's structured fields — always verify with the funder before applying.

About the funder

Centers for Disease Control - NCCDPHP is a federal-level funder.

Award amount
$350k–$500k
Deadline
2984 days ago
Jun 18, 2018
Total pool
$17.5M

About this opportunity

Cigarette smoking and exposure to secondhand smoke (SHS) is the leading preventable cause of death in the United States, resulting in approximately 480,000 premature deaths and 16 million smoking-related illnesses. Cigarette smoking can lead to increased cardiovascular disease, multiple types of cancer, pulmonary disease, adverse reproductive outcomes, and the exacerbation of chronic health conditions. Annual costs associated with tobacco-related illnesses amount to nearly $280 billion in medical expenses and lost productivity. Electronic cigarette (e-cigarette) use among youth and young adults has increased considerably, growing 900% among high school students from 2011 to 2015. Cancer is the second leading cause of death in the United States, with approximately 1.5 million new diagnoses and over 550,000 deaths each year. Commercial Tobacco use is the leading preventable cause of cancer and cancer deaths. It can cause not only lung cancer but also cancers of the mouth and throat, voice and rectum, and a type of leukemia. Each year, 660,000 people in the US are diagnosed with and 343,000 people die from a cancer related to commercial tobacco use. The direct cost of cancer care in the United States was $125 billion in 2010, and is expected to increase to $158 billion in 2020. Tobacco-Related Disparities Tobacco disparities exist among racial and ethnic groups, including persons with low socioeconomic status (SES), persons with histories of mental illnesses and substance abuse disorders, the transgender (LGBT) community, persons with disabilities, persons living in certain geographic regions, and among youth high school drop-outs. Nearly 1 in 4 LGBT adults smoke cigarettes compared with about 1 in 6 heterosexual/straight adults. Approximately 25% of adults have some form of mental illness or substance use disorder, and these adults consume almost 40% of all cigarettes smoked by adults. 2016 BRFSS estimates of current smoking rates for persons with disabilities in the US are 28.2% compared to 13.4% for persons without disabilities. The proportion of current cigarette smokers who report smoking daily is highest among smokers living in the Midwest (68.3%), and lowest among those in the West (56.9%). Differences in flavored tobacco use, including menthol, exist across states and subpopulations. Subpopulations with the greatest overall prevalence of flavored tobacco use include persons who are male, younger in non-white. Nearly 9 of every 10 African American smokers (88.5%) aged 12 years and older prefer menthol cigarettes. Disparities in the number of smokers who quit also persist among specific subpopulations including non-Hispanic blacks, persons with lower education, persons with disabilities, and persons on Medicaid or without health insurance. While information about the dangers of cigarette smoking have been provided to the public for more than 40 years, this basic information may not have reached persons who have limited English proficiency, such as those who have recently arrived in the United States, Asian Americans, Pacific Islanders and Hispanics. Forty percent of the population live in state or local communities with no comprehensive smoke-free air laws. Secondhand tobacco smoke exposure causes heart disease and lung cancer in nonsmoking adults and sudden infant death syndrome, acute respiratory infections, middle ear disease, exacerbated asthma, respiratory symptoms, and decreased lung function in children. Cancer-Related Disparities Twelve cancers are caused by commercial tobacco and evidence exists for a causal relationship with several others. Furthermore, tobacco use also impacts health outcomes in patients and survivors with these tobacco-related cancers as well as other cancers. Tobacco use could adversely affect treatment outcomes, increase all-cause and cancer specific mortality, and also increase risk for second primary cancers.

Funding agency

Tags

Want help applying?

Our specialists will check your eligibility, prepare the application, and walk you through every step — for free. Create a free account →

Who can apply

Eligibility details aren't on file yet — check the agency source link in the Documents tab for the latest rules.

Geographic eligibility

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
  • District of Columbia

How to apply

We don't have application instructions on file yet — head straight to the official source.

Apply on agency site
Tip from our team:

Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.

Need help getting in touch with the right agency contact?

Create a free account and our specialists will guide you through the application end-to-end.

Source documents

View on agency site
Canonical NOFO, application packet, and forms
No supplemental documents yet.

Direct downloads (NOFO PDFs, application forms, FAQs) will appear here once our team attaches them. For now, the agency site has the canonical packet.

Citation details

Source systemgrants.gov
Source ID302197
PostedApr 16, 2018

Frequently asked questions

No FAQs yet.

Have a question about this fund? Sign in to open a ticket about this fund.